The New York Times @nytimes
A single injection of a new drug slashed a Covid patient’s odds of being hospitalized by half, scientists found. But regulatory hurdles and a lack of funding make it unlikely to reach the U.S. market anytime soon. https://t.co/1aXkzVZScG — PolitiTweet.org